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ABSTRACT 
 
Functional development of affective and reward circuits, cognition and response inhibition later in life exhibits 
vulnerability periods during gestation and early childhood. Extensive evidence supports the model that exposure to 
stressors in the gestational period and early postnatal life increases an individual's susceptibility to future impairments of 
functional development. Recent versions of this model integrate epigenetic mechanisms of the developmental response. 
Their understanding will guide the future treatment of the associated neuropsychiatric disorders. A combination of non-
invasively obtainable physiological signals and epigenetic biomarkers related to the principal systems of the stress 
response, the Hypothalamic-Pituitary axis (HPA) and the Autonomic Nervous System (ANS), are emerging as the key 
predictors of neurodevelopmental outcomes. Such electrophysiological and epigenetic biomarkers can prove to timely 
identify children benefiting most from early intervention programs. Such programs should ameliorate future disorders in 
otherwise apparently healthy children. The recently developed Early Family-Centered Intervention Programs aim to 
influence the care and stimuli provided daily by the family and improving parent/child attachment, a key element for 
healthy socio-emotional adult life. Although frequently underestimated, such biomarker-guided early intervention 
strategy represents a crucial first step in the prevention of future neuropsychiatric problems and in reducing their personal 
and societal impact. 
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1. GESTATIONAL ENVIRONMENT AND EARLY PARENTING 
The spread and depth of evidence from both animal and human studies leave nowadays little doubt about the 
impact of the gestational environment on the fetal brain development; a concept thaW haV beeQ QaPed ³feWaO 
SURgUaPPLQg´ [1, 2]. Prenatal stress (PS) impacts early behavioural, cognitive development and temperament in human 
infants and increases child morbidity and neurological dysfunction such as attention-deficit hyperactivity disorder 
(ADHD) and sleep disturbance during infancy which if persistent in adulthood might result in depression and 
vulnerability to psychotic disorders [3, 4]. In their review, Van Den Bergh et al. [3] concluded that numerous 
epidemiological and case-control studies of the past decade show neurodevelopmental disorders in offspring exposed to 
maternal stress during pregnancy. Reviewed studies mainly refer to pregnant women exposed to psychosocial stress 
including states of anxiety, depressive symptoms, major life events experienced by the mother, experience of a disaster 
and subjective distress during the third trimester of pregnancy. These pregnant women have infants that show: less 
affective reactivity at 5 months [5], higher temperamental reactivity at 6 months [6], positive association with high 
respiratory sinus arrhythmia at 8-10 months [7], higher negative affectivity at 24 months [8], higher reaction intensity at 
24-30 months [9], and decreased cognitive functions at the age of 24 months [10]. Together, these findings point to the 
main outcome of the PS exposure being at the cognitive and emotional regulatory levels. More recently, Persson and 
Rossin-Slater [11] showed that in utero exposure to bereavement has long-lasting effects on the consumption of 
psychiatric medication both during childhood and adulthood. Children are 25% more prone to taking medication to treat 
ADHD and experience a 13% and 8% increase in the consumption of prescription drugs for anxiety and depression, 
respectively, when they reach adulthood. These data highlight the serious economic burden of pregnancy-associated 
mental illnesses generating important private and societal costs. For example, in the United States the market for 
antidepressant drugs totaled $9.6 billion in 2008. The consumption of prescription drugs for treating ADHD increased 
five times in a decade from $1.7 billion in 2003 to $9 billion in 2013. Persson and Rossin-Slater [11] also pointed out that 
LQ SZedeQ, ³mental illness accounts for a larger share of health expenditures on prescription drugs that any other 
WheUaSeXWic dUXg´. Despite these insights, we observe that the long-term health±economic impact of pregnancy-
associated psychiatric illness remains highly underappreciated, especially considering that early interventions during 
pregnancy and/or nursing periods can recover these high costs to individuals and society. 
It has also been acknowledged that not only intrauterine adversities due to maternal stress influence the 
development of the child, but also a low maternal involvement during upbringing will influence the child´s 
neurodevelopmental outcome [9, 12-15]. Several studies have shown that high levels of pregnancy-specific anxiety and 
trait anxiety during pregnancy may persist postnatally predicting higher levels of parenting stress three months after birth 
and leading to a lower parenting self-efficacy and negative perceptions of parenting-related issues [16] suggesting that 
anxiety during pregnancy interferes with an optimal preparation for parenting. This means that maternal stress during 
pregnancy and during early parenting can program physiological responses and lifetime trajectories of the infant, which 
in interaction with genetic liabilities and early-life challenges, will determine the ultimate health status. The concepts 
derived from these studies contributed to the emphasis on maternal health as a global priority for the World Health 
Organization (http://www.who.int/pmnch) and the International Monetary Fund 
(http://www.imf.org/external/np/exr/facts/mdg.htm). WHO (2016) states that: ³The bXUden Rf menWal diVRUdeUV cRnWinXeV 
to grow with significant impacts on health and major social, human rights and economic consequences in all countries of 
the world.´ ThLV UeLQfRUceV Whe Ldea WhaW QXUWXULQg caUe LQ eaUO\ OLfe LV eVVeQWLaO to enable children to become healthy and 
productive citizens with adequate intellectual skills, creativity and wellbeing [17, 18]. This means that investing in 
childhood as early as possible will impact the development of a healthy society.  
 
 
 
4 
 
1.1 Developmental Hypothesis 
SeYeUaO deYeORSPeQWaO PRdeOV haYe beeQ UeSRUWed baVed RQ BaUNeU¶V FeWaO BaVLV Rf AdXOW DLVeaVeV (FeBAD) 
hypothesis. Since 1987 and based on their studies on adult cardiovascular diseases, Barker and his group elaborated the 
hypothesis that the in utero environment may permanently program the structure and physiology of the offspring [19, 
20]. The original FeBAD hypothesis evolved to include adaptive responses or phenotypic plasticity [21]. The term 
FeBAD was later changed to include the term Health, introducing the notion that not only diseases can be shaped during 
the perinatal period but also the health outcomes. The name of the hypothesis was then agreed to become the 
Developmental Origins of Health and Disease (DOHaD) [22, 23]. An extension of this hypothesis was recently 
developed by Van den Bergh et al [24] ZhR SURSRVeV Whe ³DeYeORSPeQWaO OULgLQV Rf BehaYLRU, HeaOWh aQd DLVeaVe´ 
(DOBHaD) hypothesis, introducing two fundamental concepts: a) specific signs may announce disorders to come before 
they appear and 2) in spite of the negative impact of perinatal adversities, developmental plasticity allows timely changes 
for reversion. The DOBHaD hypothesis integrates concepts from the epigenetic field and reinforces the idea that 
understanding the process by which development responds to an insult can guide the future treatment of the disorder. 
1.2 Biological mechanisms 
In recent years, much effort has been devoted to understanding the biological mechanisms that underlie the basis 
of neurodevelopmental disorders triggered by PS.  Two questions arise sequentially: 1) What are the potential mediators 
that connect the stressed mother with the fetus? and 2) HRZ dR WheVe PedLaWRUV OeaYe ³SeUPaQeQW´ VLgQaWXUeV LQ Whe 
baby? The first question has been thoroughly reviewed by Rakers et al [4] and they conclude that the main mediators of 
maternal-fetal stress are not only the well-known cortisol but also catecholamines, reactive oxygen species (ROS), 
cytokines, serotonin/tryptophan and maternal microbiota. This implies that not only the re-programming of the 
Hypothalamic-Pituitary axis (HPA) is involved but the Sympathetic-Adrenal Medullary System (SAMS) as well, among 
other systems. 
The second question is still a matter of intense study but there is a general consensus that epigenetic 
mechanisms are the most probable link between prenatal environmental exposures and the disruption of normal brain 
function [25, 26]. Most of these mechanisms and signals have been proposed as predictive biomarkers of neurobehavioral 
outcomes but in spite of much promising research efforts, we still lack well-designed longitudinal studies of 
maternal/fetal dyads with or without stress exposure that will definitively and unequivocally correlate biological signals 
with the child behavioral outcome.  These biological signals might help to predict adverse outcomes and to involve the 
child in early stimulation programs. 
The importance of finding reliable early predictive biomarkers is highlighted by the fact that the stress situation 
is often not detected on time or the pregnant/nursing mother is unaware of the potential effect of stress on the 
disadvantageous outcome for her baby. It is well known that the brain is particularly sensitive to changes in the perinatal 
environment during early development, but the consequences of prenatal damage may not necessarily be apparent until a 
critical age when neurodevelopmental defects may be precipitated by a subsequent exposure to other insults. Most 
frequently, negative outcomes in children are discovered many years later missing many opportunities and years of 
adequate stimulation programs. In fact, several studies reported that various developmental disorders were detected at 
school age in apparently healthy children. Screening trials in healthy children from 0-5 years old showed a 16-20% 
prevalence of global developmental and communication disorders [27-29]. 
As stated by Rakers et al. [4], we believe that the effects of maternal stress on fetal development are mediated 
by a ³mXlWiSle VWUeVV-WUanVfeU mechaniVmV acWing WRgeWheU in a V\neUgiVWic manneU´.  We propose that a combination of 
PXOWLPRdaO bLRPaUNeUV ZLOO heOS WR deWecW ³aW-ULVN chLOdUeQ´ aV eaUO\ aV SRVVLbOe LQ RUdeU WR make the decision to face 
early stimulation programs, whenever no prevention measures in the mother can be timely taken [30]. In this review, we 
will describe some of the combinations of signals and biomarkers as well as early intervention programs that have proven 
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effective in reversing or ameliorating neurodevelopmental disorders in children exposed to prenatal stress. 
 
2. BIOMARKERS FOR EARLY DETECTION 
The importance of early detection of children at risk of future neurodevelopmental sequelae has been clearly 
delineated by Braun et al [31]. Although much work is still needed, there are clear hints from animal and humans studies 
WhaW afWeU cRQWUROOLQg fRU WLPe Rf VWUeVV e[SRVXUe, eaUO\ LQWeUYeQWLRQV LQ chLOdUeQ caQ aPeOLRUaWe, ³UeYeUVe´ RU ³UeSaLU´ Whe 
cognitive deficits induced by PS. As mentioned before, when the mother is unaware of her stress or the newborn has no 
apparent behavioral symptoms, the availability of predictive biomarkers is urgently needed. 
Gene-environment interactions generally involve epigenetic changes and these changes can leave stable marks 
in the genome in response to the environment, potentially altering the gene expression for life and even 
transgenerationally [32]. Indeed, this phenotypic stability and reversal under intervention are features that give these 
epigenetic changes the potential to become predictive biomarkers that allow early intervention and prevention of 
neurobehavioral risk. This hypothesis has been proposed and developed in numerous studies both in humans and in 
animal models and most of them found several genes with alterations in the methylation profile that could be identified 
as biomarkers. However, we believe these studies have two important limitations: a) most of the studies were carried out 
using candidate genes interrogating the HPA axis, on the basis that stress alters this axis, disregarding the multigenic 
nature of the stress response genes; and b) few studies have assessed altered sympathetic and vagal activity during fetal 
life as a possible consequence of prenatal stress. In the following paragraphs we will describe the most studied potential 
biomarkers, the epigenetic signatures and the emerging candidate biomarkers related to the Autonomic Nervous System 
(ANS). We refer to ANS as including SAMS and the parasympathetic (i.e., mostly vagus nerve) activities. 
 
2.1. Epigenetic biomarkers 
The SURceVV Rf µfeWaO SURgUaPPLQg´ is mediated by the impact of prenatal experience on the developing HPA 
axis. The HPA is a dynamic metabolic system that regulates homeostatic mechanisms, including the ability to respond to 
stressors [33] and which is highly sensitive to adverse early life experiences [34]. It has been suggested that the latency 
between the exposure to stress and the occurrence of the disease is pointing out to the fact that the environment triggers 
stable changes that have the potential to manifest later in life [35]. 
Several recent reviews support the hypothesis that fetal programming is mediated by epigenetic mechanisms 
that persistently alter gene transcription affecting physiology and behavior [25, 36].  Epigenetic mechanisms change the 
gene activity or expression altering the chromatin organization without modifying the genetic code. Several processes 
have been described that stably alter the gene accessibility to the transcriptional machinery such as DNA 
methylation/hydroxymethylation, histone modifications (acetylation, methylation, ubiquitination and sumoylation) and 
microRNAs modifications. However, the most highly studied and best characterized epigenetic mark, DNA methylation, 
involves a direct covalent, chemical modification of a cytosine base lying sequentially adjacent to a guanine base (thus a 
CpG dinucleotide); such methylation is a relatively stable epigenetic tag, catalyzed by a group of enzymes called DNA 
methyltransferases (DNMTs) [37]. CpG dinucleotides are relatively infrequent in the genome, and areas of comparatively 
hLgh CSG cRQWeQW haYe beeQ WeUPed µCSG LVOaQdV¶. CSG LVOaQdV WeQd WR be h\SRPeWh\OaWed cRPSaUed WR RWheU CSG VLWeV 
and are found associated with approximately 70% of known gene promoters, i.e., the regulatory, non-coding portion of a 
gene that plays a role in transcription control. Promoter DNA methylation (often in CpG islands) and gene body DNA 
methylation generally show opposite associations with gene expression. The presence of 5-methylcytosine is usually 
associated with the transcriptional silencing of the underlying DNA sequence [38, 39]. The first evidence for an 
epigenetic mechanism mediating exposure to a perinatal insult was provided by examining the epigenetic effects of 
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differences in maternal care in the rat [40]. These authors and others found that the offspring of mothers who exhibited 
reduced litter care (low licking and grooming) present in adulthood increased methylation in exon 17 of NR3C1 (Nuclear 
Receptor Subfamily 3 Group C Member 1, that encodes the glucocorticoid receptor), a change associated with a 
decreased expression of glucocorticoid receptor (GR) in the hippocampus and with an exacerbated response to stress [40-
42]. Moreover, epigenetic variations have been reported, mostly changes in DNA methylation in several brain regions, in 
animal models after prenatal exposure to stress [43], maternal separation [44] and response to variations in the mother-
offspring interaction [45, 46]. In humans, higher levels of methylation were detected in exon 1F of NR3C1 (homologous 
exon 17 in rat) in the hippocampus of suicide victims who were, in turn, victims of child abuse [47], in umbilical cord 
blood cells of children whose mothers were diagnosed with depression and anxiety during pregnancy [48] and in 
pregnant mothers undergoing chronic and war-related stress [49].   
Biomarkers are molecules that characterize the particular signature of a physiological/pathological process and 
that can be easily accessed and quantified.  To evaluate PS outcomes in newborns, biomarkers are particularly needed to 
reveal epigenetic reprogramming that occurs in the brain, an inaccessible organ in humans [50]. DNA methylation in 
blood, saliva or tissues such as placenta is, therefore, a promising biomarker candidate since: a) it is easily detectable and 
quantifiable; b) it is chemically stable and not affected by cyclic fluctuations as cortisol; c) it is an early response 
mechanism, making it a sensitive indicator. At present, changes in DNA methylation of certain genes can be monitored 
accurately in samples of human placenta and umbilical cord blood [51]. Alternatively, saliva and buccal epithelium cells 
represent an additional easily accessible source of DNA and provide information on the systemic condition of an 
individual. The procedures for obtaining saliva have the advantage of being simple, inexpensive and less invasive since 
they do not involve any side effects such as bruising, infections, etc. In addition, sampling can be done from early 
childhood onwards [48, 51]. In a recent study, Essex et al, [52] examined buccal epithelial cells in a cohort of adolescents 
and found differences in DNA methylation in those adolescents whose parents reported experiencing stress and 
depression during the adolescent childhood. 
The methods for analyzing gene-specific DNA methylation can be divided into "candidate gene" and 
"genome-wide" studies.  The ³candidaWe gene´ approach directly tests the effects of genetic variants of a potentially 
contributing gene in an association study [53] thus excluding a large number of genes. In contrast, the Epigenome-Wide 
Association Studies (EWAS) approach allows an unbiased analysis of locus-specific methylation across an entire 
genome. Thanks to the incorporation of microarray-based methylation profiling platforms, this technique is now 
relatively inexpensive. All studies summarized in the preceding paragraphs were performed interrogating candidate genes 
based on the hypothesis that DNA methylation in brain regions of the fetus is related with the fetal HPA axis response to 
maternal stress.  
However, the multigenic nature of the stress response and neuropsychiatric disorders, is manifested through 
small and simultaneous changes in the expression of several genes [54]. Accordingly and beyond the HPA axis genes, 
Vidal et al [55], found alterations in the methylation in the differentially methylated region (DMR) of MEST gene 
(Mesoderm Specific Transcript) and more recently, Vangeel et al [56], found an association between methylation of a 
gene IGF2 DMR (Insulin family of Growth Factors) with pregnancy-associated anxiety. However, recent publications 
employing the EWAS approach have shown contradictory results. Combining data from two independent population-
based samples in an EWAS meta-analysis (n=1740 dyads), Rijlaarsdam et al. [57], showed no large effects of prenatal 
maternal stress exposure on neonatal cord blood DNA methylation. More recently, Wikenius et al. [58] studying prenatal 
maternal stress (n=184 dyads), in the form of maternal depressive symptoms, found no significant genome-wide 
association between maternal depressive symptoms and infant DNA methylation. In contrast, Non et al. [59] reported the 
identification of 42 CpG sites with significantly different cord blood DNA methylation levels in neonates (n=36) exposed 
to non-medicated depression or anxiety relative to controls. Interestingly, they report that after a gene ontology analysis 
they found a significant clustering of genes related to transcription, translation, and cell division processes, but no genes 
were related to the HPA axis. Employing a cross-tissues/cross-species study of the effects of early life stress (ELS) using 
a genome-wide approach, Nieratschker et al. [60] found that MORC1 (MORC family CW-type zinc finger 1, a protein 
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required for spermatogenesis) was differentially methylated in humans (n=180 dyads), monkey and rat both in peripheral 
tissues as well as in the brain and at different time points throughout life-span. Other studies investigated extreme 
conditions of ELS, such as war situations or natural disasters and found broad effects of ELS on methylation in several 
genes of the HPA axis in a war-related stress situation (n=24 dyads) [49], while Cao-Lei et al. [61] reported that PS in the 
form of a natural disaster (Ice-Storm in Quebec) was correlated with DNA methylation (in T-cells of 13 years old 
children) in 1675 CGs associated with 957 genes related to immune function. It is probably too early to draw general 
conclusions based on these studies since many differences are still observed in terms of the type and timing of prenatal 
insult, tissue employed and the children´s age. 
Histone and miRNA modifications are also promising biomarkers of PS. Even though most of these studies 
come from animal models, several biomarkers were shown to be related to neurological diseases in humans [62-65].  In 
our studies, PS was shown to increase miRNA-133 in prefrontal cortex and hippocampus of in PS male rats [66] and an 
increase in histone methyltransferase suv39h1 in hippocampus of PS offspring, with no changes in histone deacetylases 
hdac2 and hdac3 mRNA levels [67]. Zucchi et al. [65] showed that several miRNA profiles were up-regulated in PS 
offspring brains (miR145 and miR103) and several were down-regulated (miR323, miR98 and miR219). At the protein 
level and employing a mouse model, Benoit et al. [68] showed that adult offspring exposed to unpredictable chronic 
stress during pregnancy exhibited decreased acetylated histone H3 (AcH3) in the hippocampus with sex-specific changes. 
In accordance with the gender differences for miRNA-133 in male rats, Van Den Hove et al. [69] showed an up 
regulation of histone deacetylase 4 protein (HDAC4) in the hippocampus of prenatal restraint stress (PRS) male 
offspring, while it was down regulated in frontal cortex of PS female offspring.  
In summary and in spite of the disparity of these findings, overall there is ample evidence supporting the 
hypothesis that PS produces stable and long-term phenotypic changes in the offspring involving persistent alterations in 
gene function through changes in DNA methylation, histone and miRNA modifications. Although further use of the 
epigenome-wide approach will clarify this association, it seems plausible to envision epigenetic marks as biomarkers for 
children at-risk of suffering developmental diseases. 
 
2.2. Biomarkers of the Autonomic Nervous System 
HPA-axis oriented studies have overlooked other physiological signs. For example, corticosteroid 
administration during pregnancy has shown to affect autonomic balance in utero [70-73]. This effect is transient but 
repeated fetal administration of betamethasone alters nervous system maturation. In fact, Braithwaite et al. [74] found no 
association between maternal cortisol and infant DNA methylation suggesting that the effects of maternal depression 
may not be mediated directly by glucocorticoids; instead, sympathetic nervous system activity, a component of the fetal 
ANS, may be the mediating pathway. 
The fetal ANS has proven to be very sensitive to maternal stress [75-77]. Among other authors, Kinsella and 
Monk [78] and Gao et al. [79] have indicated that common biomarkers of ANS such as Fetal Heart Rate (FHR) reactivity 
to a stimulus, or heart rate variability, reflect emerging individual differences in the development of the autonomic and 
central nervous systems related to styles of future emotional regulation and the risk for psychopathology. 
 Advanced analysis of FHR patterns specifically assessing changes in the autonomic regulation of FHR may 
identify the fetus at increased risk for fetal programming. This can be assessed by a relatively new promising method, 
phase-rectified signal averaging (PRSA) analysis of FHR, measured by electrocardiography (ECG) or cardiotocography 
(CTG) [80, 81]. PRSA can eliminate signal artifacts and extract areas of interest from FHR. In contrast to other methods 
analyzing FHR variability, PRSA permits the detection of quasi-periodicities in non-stationary data, an important benefit 
of the PRSA approach in dealing with an often-noisy FHR signal.  Schmidt and his team already reported the excellent 
performance of PRSA in adult cardiology for predicting mortality after myocardial infarction [80]. This method was first 
described for fetuses by our own research group [82-84]. PRSA has then been successfully applied in fetal medicine also 
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by other teams, despite the challenges of a non-stationary signal, with more intrinsic disturbances in the signal than in the 
adult after a myocardial infarction. The novel parameter referred to as cardiac average acceleration and deceleration 
capacity is more specific than the conventional FHR analyses in identifying intrauterine growth restriction (IUGR) 
antepartum [83-85], predicting IUGR outcome and strongly correlates with acid-base biomarkers during acute hypoxic 
stress in humans during labor [86, 87] and the fetal sheep model of labor [88]. Newer data also show an activation of 
ANS in fetuses affected by maternal gestational diabetes which could not be seen using conventional techniques [89]. To 
evaluate the ANS influence on FHR using PRSA approach, the beat-to-beat information (R-R intervals of ECG) should 
be analyzed, although the conventional Doppler CTG signal can also be used for the analysis. The new generation of the 
trans-abdominal fetal ECG monitors (such as Monica AN24, Monica Healthcare, Nottingham, UK or Invu by Nuvo-
Group, Tel Aviv, Israel) allows for a completely non-invasive and passive recording of fetal and maternal ECG: it only 
UecRUdV eOecWURSh\VLRORgLcaO VLgQaOV fURP Whe ZRPeQ¶V abdRPeQ ZLWhRXW haPSeULQg PRbLOLW\ RU RWheU dLagQRVWic 
procedures. This signal can then be used for a more sophisticated analysis of FHR such as PRSA or multidimensional 
FHR variability analysis [90]. 
We have recently assessed couplings between maternal heart rate (MHR) and FHR as a new biomarker for PS 
based on a signal-processing algorithm termed bivariate PRSA (bPRSA) yielding fetal stress index (FSI) values by 
jointly assessing changes in MHR and FHR. In a prospective case-control study matched for maternal age, parity and 
gestational age, we used the Cohen Perceived Stress Scale-10 (PSS-10) questionnaire to categorize women in the 3rd 
trimester of pregnancy as stress group and control group. We could detect periodic MHR decreases reflecting typical 
SaWWeUQ Rf PaWeUQaO bUeaWhLQg (VLQXV bUad\caUdLa dXULQg e[SLUaWLRQ). IQWeUeVWLQgO\, cRQWURO gURXS feWXVeV UePaLQed ³VWabOe´ 
during these periods whereas fetuses of stressed mothers showed significant decreases of FHR. The proposed FSI 
provides unique insights into the relationship between two connected biological systems: mother and fetus. It is hence 
likely that the FHR response to MHR changes represents a fetal stress memory and may serve as a novel biomarker to 
detect PS effects early in utero which may help guide early interventions prenatally and postnatally [91]. 
After birth, ANS activity can also be assessed by measuring the baroreceptor reflex sensitivity (BRS). To 
improve the signal to noise ratio and hence the quality of BRS estimation, non-invasive continuous blood pressure 
monitoring with Finapres is used to obtain systolic blood pressure information, combined with a simultaneous ECG 
recording to extract a high-quality R-R signal and compute the pulse. A bivariate PRSA method, akin to FSI, is then 
applied for BRS calculation [92]. This method allows the correlation of blood pressure with ECG giving complementary 
insights into ANS. This approach has never been deployed in neonates and infants affected by fetal programming before 
and seems to be a very promising tool for this patient group. 
Human studies pose various challenges in terms of confounding factors and accessibility to brain tissues. Future 
studies will hence require a combination of non-invasive physiological measures of the stress response system that are 
unequivocally linked to PS and that could be deployed as predictive biomarkers of the child neurodevelopmental 
outcomes. By integrating multiple non-invasively obtainable sources of information this framework could yield progress 
in maternal, fetal and child health, offering a more precise and personalized prediction and new possibilities for designing 
interventions to improve neurodevelopmental outcomes of pregnancy affected by PS. 
 
3. EARLY INTERVENTION PROGRAMS IN CHILDREN 
The biological rationale for designing Early Intervention Programs (EIP) is based on the well-known property of 
the brain known as cerebral plasticity. As elegantly synthesized by Brenhouse and Andersen [93]:  ³While geneV SURYide 
the blueprint to construct the brain, experience sculpts that brain to match the needs of the environment´. AVVXPLQg WhaW 
the conditions are favorable, there is a time window during which brain functions develop normally; however, during 
anomalous conditions, there is a sensitive period during which the structure or function can be modified.  This adaptation 
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to the needs of the environment implies that environmental influences such as stress have a significant impact on brain 
development. One of the roles of cerebral plasticity is correcting anomalous cognitive development and may have 
favorable effects even if the change it induces does not reproduce the normal sequence of normal development. Since the 
young brain has a higher potential towards plasticity, intervention programs are devised as early as possible aiming at 
stimulating the brain during the periods of its plasticity so that such neuroplasticity processes may correct the abnormal 
cognitive development [94-96]. 
Although it seems logical to assume that maternal stress during pregnancy would lead to parenting stress during 
nursing, few studies have addressed this important topic. Among these studies, Huizink et al. [16] observed that 
pregnancy-specific anxiety and trait anxiety predict higher levels of parenting stress 3 months after birth. As observed by 
Mc Quillan et al. [97], postnatal stress leads to poor and insufficient sleep which in turns leads to to less observed 
positive parenting practices and more self-reported dysfunctional parenting. More recently, Hagaman et al [98] showed 
that, in a peri-urban cohort in Pakistan, depression and stress during pregnancy were significantly associated with poor 
maternal functioning in everyday life during the first year after birth. It is, therefore, plausible to predict that the 
neurodevelopmental outcome in terms of affective and reward circuits, cognition, mood, emotional regulation, 
personality and learning abilities of the infant would be shaped by the antenatal exposure to maternal stress and 
subsequent less than optimal parenting. Inversely, it has been demonstrated that engaging in positive parenting practices, 
such as reading to children, engaging in storytelling or singing and eating meals together as a family may influence a 
child's future success in the educational system and reduce the risk for delays at the developmental, social and behavioral 
levels [99]. According to Garg et al. [100], ³The quality of the early care environment can buffer some of the negative 
effects of prenatal adversity on child development´ aQd aW Whe PROecular level. These authors demonstrated that the early 
care environment co-varies with variation in genome-wide DNA methylation in middle childhood meaning that there is 
an association between infant attachment at 36 months of age and DNA methylome variation in later childhood. 
Excluding pathological outcomes, there is again little research directed at correlating the influence of both 
prenatal and postnatal unfavorable environments on the offspring´s behavior, particularly on how the environment will 
impact on the infant personality and character. Two recent studies show that environmental harshness and hawk character 
during the first two years of life predicted worse visual-problem solving at 4 years of age [101] and that children´s 
temperamental predispositions, paired with a history of regulatory problems in infancy and maternal depressive 
symptoms contribute to an increased risk of behavioral problems [15], pinpointing the influence of early disadvantageous 
environments and character on behavioral and cognitive abilities in later life.  
In the face of this body of evidence, the development of EIP is urgently needed to ameliorate these undesired 
behavioral and cognitive outcomes and to aid parents whose babies were exposed to PS.  The hLVWRU\ Rf ³EaUO\ 
SWLPXOaWLRQ PURgUaPV´, as were originally called, dates back to 1965 when a publicly funded program was created in the 
United States for vulnerable children in low-income families [102]. Since then, most of the early stimulation programs 
have been targeted to neurodevelopmentally impaired or preterm or low-birth-weight infants. Even though there are no 
specific programs designed for babies that were exposed to PS, the wealth of programs developed to stimulate children 
and to improve parenting abilities are extremely valuable antecedents that will help to choose the appropriate intervention 
strategy for an early stimulation program oriented toward prenatally stressed babies. As mentioned above, these babies 
deYeORS aV ³aSSaUeQWO\ heaOWh\ chLOdUeQ´ XQWLO gORbaO deYeORSPeQWaO and communication disorders are diagnosed many 
years later, sometimes at school age. 
Since summarizing the existing literature on the EIP is out of the scope of this review, we will briefly outline the 
main benefits reported in selected studies. According to Bonnier [95], EIP have been developed for three different target 
populations: 1) Low socioeconomic status children at-risk, 2) Children with disorders that induce developmental delays 
(e.g. Down Syndrome, Cerebral Palsy) and 3) Preterm or low weight babies. Cognition improvements are greater than 
motor skills [95] although other studies point out that there are moderate effects on cognitive and behavioral outcomes 
[103] and improved visual and motor skills during infancy [104] but that cognitive benefits persist into preschool age 
[105].  In spite of the different targeted populations and the heterogeneity between studies, most reviews concur that EIP 
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produce the greatest positive effects when the programs involve both parents and the child and that long-term stimulation 
programs improved child-parent interactions [95, 96]. 
In this sense, a recent review [106] and a meta-analysis [107] report the results of several studies employing 
different programs involving parents and children known as: Early Interventions focused on the family or Early Family-
Centered Interventions. This approach aims at improving the parent-infant interactions and relationship resulting in an 
improvement in the child´s development and increased resilience. Although its effectiveness has yet to be fully proven, 
parental psychosocial support is a sensible approach to increase parent´s ability and knowledge to care for their child. 
Parent´s support is intended to reduce stress, anxiety and depression as well as improving the parent´s attunement and 
capacity to interact with their child, which will eventually improve the developmental outcomes. Intuitively, it is clear 
that building a strong parent-infant relationship will help the infant learn self-regulatory skills such as crying but being 
consolable, self-soothing, sleep-wake changes and feeding [106]. As mentioned before, most of these programs targeted a 
cohort of preterm babies and only one study assessed children at social risk excluding preterm children. In any case, and 
although the age of the babies, the assessment tools and the programs differed among studies, all interventions involved 
components of guidelines for parents to stimulate child development through improving reciprocity in parent/baby 
relationship and a better understanding of the child´s needs. In spite of the mentioned heterogeneities in study design, the 
overall conclusion was that Early Family-Centered Intervention Programs improved the cognitive and motor 
development in preterm infants when compared to the standard care.  
 
4. PERSONALIZED AND PREVENTIVE MEDICINE: FROM EARLY LIFE HEALTH 
MONITORING TO EARLY LIFE PREVENTION PROGRAMS 
Figure 1 summarizes how we envision the connection between prospective studies and the identification of 
biomarkers with the administration of EIP that will lead to a personalized and preventive medicine for babies exposed to 
PS.  
In the Prospective Study section of the Figure we illustrate that stressed pregnant women in their third trimester 
are categorized as stressed with PSS (Cohen Perceived Stress Scale questionnaire, PSS-10) and controls matched for 1:1 
for parity, maternal age, and gestational age at study entry. Two and a half weeks after screening, a transabdominal ECG 
(taECG) recording at 900 or 1000 Hz sampling rate of at least 40 min is performed to compensate for inevitable signal 
artifacts. From fetal and maternal ECG, fetal and maternal R-peaks are detected and to derive the FHR and MHR. The 
bPRSA method is used to quantify interactions between FHR and MHR as a measure of transfer of maternal stress onto 
fetus (Fetal Stress Index, FSI). This measure uniquely captures biophysical dynamics of mother-fetus dyad. Maternal 
serum is obtained to detect total cholinergic status as the total capacity for acetyl choline (ACh) hydrolysis (that is, the 
summation of ACh esterase, AChE, and butyl choline esterase, BChE, activities). Cholinergic status, especially the ratio 
of AChE/BChE, has been shown to be a sensitive indicator of chronic stress exposure in adults, but its role as stress 
biomarker in a developing organism remains to be fully elucidated [108-110]. AChE activity levels are assessed in the 
maternal serum and cord blood samples with a specific BChE inhibitor, by using a microtiter plate assay (MPA). On the 
day of parturition, hair strands are collected from the posterior vertex region on the head, as close to the scalp as possible, 
for cortisol measurement using Automated Chemiluminescent ImmunoAssay (CLIA). Based on an approximate hair 
growth rate of 1 cm per month, the proximal 3 cm long hair segment is assumed to reflect the integrated hormone 
secretion over the three-month-period prior to sampling [111]. 
Soon after birth, a neonatal specialized midwife collects a saliva/buccal sample from the newborn by gentle 
rubbing the gums on both sides with a special device and stores it at room temperature. DNA from the infant saliva 
sample is extracted and methylation is measured using the Infinium HumanMethylation EPIC beadchip array or similar 
technologies. Cord blood serum for miRNA detection and AChE/BChE analysis is also collected. 
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AW 24 PRQWhV Rf age, LQfaQWV¶ deYeORSPeQW LV aVVeVVed b\ Whe geUPaQ YeUVLRQ Rf  Ba\Oe\ ScaOe Rf Infant  
Development Third Edition (BSID-III). The BSID-III is composed from a series of subtests aimed at evaluating 
cognitive, language and motor skills on infants from 16 days to 42 months. A specialized professional, who is blind 
regarding maternal stress categorization, administers the tests, which lasts about 120 minutes. A new saliva sample is 
collected from the infant at this final visit for epigenetic analysis. Based on the assumption that PS imprints these 
phenotypic modalities permitting a mutual inference, we examine putative relationships between the measures derived 
from all epigenetic biomarkers, FHR analyses techniques and maternal and child cognitive assessments. One key 
challenge is the integration of heterogeneous datasets, such as multidimensional HRV indices, the epigenetic 
information, and biochemistry indices.  With the entire multimodal cohort data, the machine learning tools build 
predictive models of the relationship between PS and the different multimodal biomarkers. With the generated model, 
clinicians can make predictions for the effects of PS on later neurodevelopment, e.g., by using taECG and cord-blood 
samples to predict BSID at 2 years of life.  
In the Personalized and Preventive Medicine section of the Figure, we highlight the significance of this 
proposal stressing the importance of identifying early non-invasive pre- and postnatal biomarkers of brain programming 
due to intrauterine stress exposure. This will help to predict adverse postnatal brain developmental trajectories, which is a 
prerequisite for designing EIP. EIP improve long-term developmental trajectories and may prevent development of health 
abnormalities entirely.  Using an unprecedented multimodal combination of epigenomic predictors and clinical health 
outcomes such as prenatal stress, FHR analyses in utero and epigenetic alterations in newborns promises new insights 
into the early causes of neuropsychological dysfunction during early childhood.  
 
 
CONCLUSION 
Stress and anxiety during pregnancy increase risk for poor child neurodevelopment. If stress persists during the 
nursing period, it will lead to deficient parenting interfering with the mother-infant attachment. This implies that during 
critical periods of brain development, i.e., pregnancy and nursing periods, the baby is subjected to environmental 
negative influences known to shape developmental trajectories, including neuronal connections. This apparently healthy 
baby, if exposed to a repeated stressful situation later in life, may show impairments in the functional development of 
affective and reward circuits, cognition and response inhibition. 
There is now a general consensus that both stress systems, namely the HPA and the SAMS, leave permanent 
epigenetic marks in selected genes that if adequately linked to the neurodevelopmental disorders can emerge as reliable 
predictive biomarkers. In addition, simultaneous maternal-fetal heart rate monitoring is emerging as a novel early PS 
biomarker. Since the pregnant and nursing mother can be unaware of her stress situation or of the harmful consequences 
to her child, the identification and characterization of biomarkers that can timely predict adverse postnatal brain 
developmental trajectories, is urgently needed and a prerequisite for designing therapeutic interventions.  The recently 
developed Early Family±Centered Intervention programs aim to support family dynamics in the domestic environment 
and are highly recommended due to the possibility of improving the care and stimuli offered daily to the infant.  
By integrating multiple non-invasively obtainable sources of information using novel epigenetic, 
electrophysiological and machine learning methods, unambiguously linked to the disorders, this approach could yield 
progress in maternal±fetal medicine, pediatrics and developmental psychology, offering a more precise and personalized 
prediction and new possibilities for designing early interventions to improve neurodevelopmental outcomes of pregnancy 
affected by PS. This is an important first step in preventing neuropsychological problems and in reducing their personal 
and societal impact. 
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FIGURE LEGENDS 
FIGURE 1 
a) PROSPECTIVE STUDY  
Schematic representation of a Prospective Matched Case/Control study to derive biomarkers of prenatal stress. 
Pregnant women in their third trimester are screened and a transabdominal electrocardiogram (taECG) is perfomed two 
and a half week after screening.  The bivariate Phase Rectified Signal Averaging (bPRSA) method is used to quantify 
interactions between fetal and maternal Heart Rate (fHR and mHR) as a measure of transfer of maternal stress onto the 
fetus (Fetal Stress Index, FSI). Maternal serum is obtained to detect total cholinergic status as the total capacity for ACh 
hydrolysis by Acetyl and Butyryl Cholinesterase  (AChE and BChE activities) using a microtiter plate assay (MPA). On 
the day of parturition maternal hair strands are collected for cortisol measurement using automated Chemoluminiscent 
ImmunoAssay (CLIA). Upon delivery, saliva and serum samples are collected from the newborn. DNA from the infant 
saliva sample is extracted and methylation is measured, e.g., using the Infinium HumanMethylation EPIC beadchip array. 
Cord blood serum for miRNA detection and AChE/BChE analysis, is also collected. At two years of age, the mother is 
invited to return with the toddler to evaluate the neurocognitive development assessed by Bayley Scale III of Infant 
development (BSID). Machine learning analysis will examine putative relationships between the measures derived from 
all epigenetic and molecular biomarkers, FSI and maternal and child cognitive assessments. 
 
 
b) PERSONALIZED AND PREVENTIVE MEDICINE 
Timely assessment of non-invasive biomarkers for pregnant women and newborns will allow early detection of 
the babies-at-risk. This will help choosing the appropiate Early Intervention Program (EIP) and improve child 
development. Ultimately, such approach will help prevent long-term neuropsychological problems. Such intervention 
programs should ameliorate future disorders in otherwise apparently healthy children reducing the personal and societal 
impact of such disorders. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 

